Lowest Price Guaranteed From USD 5,899
Published
January 2023
Pages
183
View Count
2455
Example Insights
 |
 |
 |
 |
 |
 |
 |
 |
 |
Report Description
The concept of 3D printing has been one of the biggest revolutions across the globe. Various industry stakeholders and academicians have undertaken several initiatives to further develop / improve this technology for a variety of applications. One such application area is 3D bioprinting that includes the printing of living cells and enables the development of highly complex tissues that mimic the structure and performance ability of desired organ, within the body. Although 3D bioprinting results in the printing of an exact replica of primary human organs, however, the printed 3D objects are inert and static in nature and are unable to change shape when subjected to environmental changes. 4D bioprinting makes this possible; 4D bioprinting refers to the incorporation of a fourth dimension that enables these structures to change their shape with time. The additional element in the bioprinting technology that enables the fourth dimension, includes application of smart materials, which have the tendency to morph in the presence of stimuli (such as, heat, water, light, electricity, magnetic energy, stress, strain, and pressure). In addition to the ability to morph, these 4D printed structures have the ability to self-repair and can adapt to various environmental changes. This technology, though, is currently associated with several challenges; these include printing the existing stimuli-responsive materials and optimizing them with bio-inks. Assembling and folding deformations in 4D printed structures is also quite demanding.
Owing to the ongoing advancements in the 4D biofabrication technology, several players are actively adopting and developing 4D bioprinters and smart biomaterials. It is worth highlighting that 4D bioprinting is garnering a lot of attention from academicians and industry players. In fact, the volume of affiliated scientific literature has increased at a rate of ~130% since last five years, demonstrating the growing popularity of 4D bioprinting. Further, looking at the wide range of applications associated with the 4D bioprinting, such as tissue engineering, regenerative medicine, and drug related applications, a number of start-ups have also emerged in this domain. Given the rising interest of stakeholders towards technological advancements and growing adoption of 4D bioprinting for above mentioned applications, we believe that the overall market for 4D bioprinting is anticipated to witness substantial growth in the coming years.
The 4D Bioprinting Market – Distribution by Type of Technology (Extrusion-based Technology, Laser-based Technology, Inkjet-based Technology and Others), Application Area (Biomedical Applications and Others), End-user (Pharmaceutical and Biotechnology Companies, Academic Research and Development and Other End-users) and Key Geographical Regions (North America, Europe, Asia-Pacific, Latin America and Middle East and North Africa): Industry Trends and Global Forecasts, 2023-2035 report features an extensive study of the current market landscape and future potential of the 4D bioprinting market. The study features an in-depth analysis, highlighting the capabilities of 4D bioprinter and smart biomaterial developers. Amongst other elements, the report includes:
One of the key objectives of the report was to evaluate the current opportunity and future potential associated with the 4D bioprinting market, over the coming 12 years. We have provided informed estimates of the likely evolution of the market in the short to mid-term, and long term, for the period 2023-2035. Our year-wise projections of the current and future opportunity have further been segmented based on relevant parameters, such as type of technology (extrusion-based technology, laser-based technology, inkjet-based technology and others), application area (biomedical applications and others), end-user (pharmaceutical and biotechnology companies, academic research and development and other end-users), key geographical regions (North America, Europe, Asia-Pacific, Latin America and Middle East and North Africa). To account for future uncertainties in the market and to add robustness to our model, we have provided three forecast scenarios, portraying the conservative, base and optimistic tracks of the market’s evolution.
The opinions and insights presented in the report were also influenced by discussions held with senior stakeholders in the industry. The report features detailed transcripts of interviews held with the following individuals:
The study presents an in-depth analysis of the various firms / organizations that are engaged in this domain, across different segments as defined in the below table:
| Report Attributes | Details | |
|
Forecast Period |
2023 – 2035 |
|
|
Type of Technology |
Extrusion-based Technology, Laser-based Technology, Inkjet-based Technology, Other Technologies |
|
|
Application Area |
Biomedical Applications, Other Applications |
|
|
End-user |
Pharmaceutical and Biotechnology Companies, Academic Research and Development, Other End-Users | |
|
Key Geographical Regions |
North America, Europe, Asia-Pacific, Latin America, Middle East and North Africa |
|
|
Key Companies Profiled |
DirectSync Surgical, Enovis, Ferentis, Poietis, REGENHU, ROKIT Healthcare, Sculpteo, SMART3D, Stratasys, VIVAX BIO |
|
| Customization Scope | 15% Free Customization Option (equivalent to 5 analysts working days) | |
| PowerPoint Presentation (Complementary) | Available | |
| Excel Data Packs (Complimentary) | 4D Bioprinters: Market Landscape Analysis, Smart Biomaterials: Market Landscape Analysis, Benchmarking Analysis, Product Competitiveness Analysis, Market Forecast and Opportunity Analysis | |
Contents
1. PREFACE
1.1. Scope of the Report
1.2. Market Segmentation
1.3. Research Methodology
1.4. Key Questions Answered
1.5. Chapter Outlines
2. EXECUTIVE SUMMARY
3. INTRODUCTION
3.1. Chapter Overview
3.2. Overview of 4D Bioprinting
3.3. Working Principle of 4D Bioprinting
3.3.1. Stimuli Responsive Materials in 4D Bioprinting
3.3.1.1. Physical Factors
3.3.1.2. Chemical Factors
3.3.2. Technologies Used in 4D Bioprinting
3.4. Applications of 4D Bioprinting
3.5. Limitations Associated with 4D Bioprinting
3.6. Future Perspectives
4. 4D BIOPRINTERS: MARKET LANDSCAPE
4.1. Chapter Overview
4.2. 4D Bioprinters: Overall Market Landscape
4.2.1. Analysis by Status of Development
4.2.2. Analysis by Type of Biomaterial
4.2.3. Analysis by Status of Development and Type of Biomaterial
4.2.4. Analysis by Type of Technology
4.2.5. Analysis by Status of Development and Type of Technology
4.2.6. Analysis by Type of Stimulus Used
4.2.7. Analysis by Status of Development and Type of Stimulus Used
4.2.8. Analysis by Product Specifications
4.2.9. Analysis by Application Area(s)
4.2.10. Analysis by End-User(s)
4.3. 4D Bioprinter Developers
4.3.1. Analysis by Year of Establishment
4.3.2. Analysis by Organization Size
4.3.3. Analysis by Location of Headquarters (Region-wise)
4.3.4. Analysis by Organization Size and Location of Headquarters (Region-wise)
4.3.5. Analysis by Location of Headquarters (Country-wise)
5. SMART BIOMATERIALS: MARKET LANDSCAPE
5.1. Chapter Overview
5.2. Smart Biomaterials: Overall Market Landscape
5.2.1. Analysis by Status of Development
5.2.2. Analysis by Type of Biomaterial
5.2.3. Analysis by Status of Development and Type of Biomaterial
5.2.4. Analysis by Form of Biomaterial
5.2.5. Analysis by Type of Stimulus Used
5.2.6. Analysis by Status of Development and Type of Stimulus Used
5.2.7. Analysis by Application Area(s)
5.3. Smart Biomaterials Developers
5.3.1. Analysis by Year of Establishment
5.3.2. Analysis by Organization Size
5.3.3. Analysis by Location of Headquarters (Region-wise)
5.3.4. Analysis by Organization Size and Location of Headquarters (Region-wise)
5.3.5. Analysis by Location of Headquarters (Country-wise)
6. BENCHMARKING ANALYSIS
6.1. Chapter Overview
6.2. Benchmarking Analysis: 4D Bioprinter Developers
6.2.1. Assumptions and Key Parameters
6.2.2. Methodology
6.2.3. Benchmarking Analysis: Peer Groups
6.2.3.1. Benchmarking Analysis: North America (Peer Group I)
6.2.3.2. Benchmarking Analysis: North America (Peer Group II)
6.2.3.3. Benchmarking Analysis: Europe, Asia-Pacific and Rest of the World (Peer Group III)
6.2.3.4. Benchmarking Analysis: Europe, Asia-Pacific and Rest of the World (Peer Group IV)
6.2.3.5. Benchmarking Analysis: Europe, Asia-Pacific and Rest of the World (Peer Group V)
6.3. Benchmarking Analysis: Smart Biomaterials Developers
6.3.1. Assumptions and Key Parameters
6.3.2. Methodology
6.3.3. Benchmarking Analysis: Peer Groups
6.3.3.1. Benchmarking Analysis: North America (Peer Group I)
6.3.3.2. Benchmarking Analysis: North America (Peer Group II)
6.3.3.3. Benchmarking Analysis: Europe, Asia-Pacific and Rest of the World (Peer Group III)
6.3.3.4. Benchmarking Analysis: Europe, Asia-Pacific and Rest of the World (Peer Group IV)
6.3.3.5. Benchmarking Analysis: Europe, Asia-Pacific and Rest of the World (Peer Group V)
7. PRODUCT COMPETITIVENESS ANALYSIS
7.1. Chapter Overview
7.2. Assumptions and Key Parameters
7.3. Methodology
7.4. Product Competitiveness Analysis: Analysis by Location of Headquarters of 4D Bioprinter Developers
7.4.1. Product Competitiveness Analysis: 4D Bioprinters Developed by North America based Players
7.4.2. Product Competitiveness Analysis: 4D Bioprinters Developed by Europe based Players
7.4.3. Product Competitiveness Analysis: 4D Bioprinters Developed by Asia-Pacific and Rest of the World-based Players
8. COMPANY PROFILES
8.1. Chapter Overview
8.2. List of 4D Bioprinter Developers
8.2.1. Poietis
8.2.1.1. Company Overview
8.2.1.2. Product Portfolio
8.2.1.3. Recent Developments and Future Outlook
8.2.2. REGENHU
8.2.2.1. Company Overview
8.2.2.2. Product Portfolio
8.2.2.3. Recent Developments and Future Outlook
8.2.3. ROKIT Healthcare
8.2.3.1. Company Overview
8.2.3.2. Product Portfolio
8.2.3.3. Recent Developments and Future Outlook
8.2.4. SMART3D
8.2.4.1. Company Overview
8.2.4.2. Product Portfolio
8.2.4.3. Recent Developments and Future Outlook
8.2.5. Stratasys
8.2.5.1.1. Company Overview
8.2.5.1.2. Financial Information
8.2.5.1.3. Product Portfolio
8.2.5.1.4. Recent Developments and Future Outlook
8.2.6. VIVAX BIO
8.2.6.1. Company Overview
8.2.6.2. Product Portfolio
8.2.6.3. Recent Developments and Future Outlook
8.3. List of Smart Biomaterials Developers
8.3.1. DirectSync Surgical
8.3.1.1. Company Overview
8.3.1.2. Product Portfolio
8.3.1.3. Recent Developments and Future Outlook
8.3.2. Enovis
8.3.2.1. Company Overview
8.3.2.2. Financial Information
8.3.2.3. Product Portfolio
8.3.2.4. Recent Developments and Future Outlook
8.3.3. Ferentis
8.3.3.1. Company Overview
8.3.3.2. Product Portfolio
8.3.3.3. Recent Developments and Future Outlook
8.3.4. Sculpteo
8.3.4.1. Company Overview
8.3.4.2. Product Portfolio
8.3.4.3. Recent Developments and Future Outlook
9. PUBLICATION BENCHMARKING ANALYSIS
9.1. Chapter Overview
9.2. Scope and Methodology
9.2.1. Analysis by Year of Publication
9.2.2. Analysis by Type of Article
9.2.3. Word Cloud Analysis: Emerging Focus Areas
9.2.4. Popular Publishers: Analysis by Number of Publications
9.2.5. Popular Journals: Analysis by Number of Publications
9.2.6. Analysis by Journal Impact Factor
9.2.7. Popular Journals: Analysis by Journal Impact Factor
9.2.8. Popular Funding Bodies: Analysis by Number of Publications
9.2.9. Publications: Timeline Analysis
9.2.9.1. Timeline Analysis of Article Type
9.2.9.2. Timeline Analysis of Journal Impact Factor Range
9.2.10. Publication Benchmarking
10. PORTER’S FIVE FORCES ANALYSIS
10.1. Chapter Overview
10.2. Assumptions and Key Parameters
10.3. Methodology
10.3.1. Threats of New Entrants
10.3.2. Bargaining Power of Buyers
10.3.3. Bargaining Power of Suppliers
10.3.4. Threats of Substitute Products
10.3.5. Rivalry Among Existing Companies
10.4. Concluding Remarks
11. MARKET FORECAST AND OPPORTUNITY ANALYSIS
11.1. Chapter Overview
11.2. Forecast Methodology and Key Assumptions
11.3. Overall 4D Bioprinting Market, 2023-2035
11.3.1. 4D Bioprinting Market, 2028 and 2035: Distribution by Type of Technology
11.3.1.1. 4D Bioprinting Market for Extrusion-based Technology, 2023-2035
11.3.1.2. 4D Bioprinting Market for Laser-based Technology, 2023-2035
11.3.1.3. 4D Bioprinting Market for Inkjet-based Technology, 2023-2035
11.3.1.4. 4D Bioprinting Market for Other Technologies, 2023-2035
11.3.2. 4D Bioprinting Market, 2028 and 2035: Distribution by Application Area
11.3.2.1. 4D Bioprinting Market for Biomedical Applications, 2023-2035
11.3.2.2. 4D Bioprinting Market for Other Applications, 2023-2035
11.3.3. 4D Bioprinting Market, 2028 and 2035: Distribution by End-User
11.3.3.1. 4D Bioprinting Market for Pharmaceutical and Biotechnology Companies, 2023-2035
11.3.3.2. 4D Bioprinting Market for Academic Research and Development, 2023-2035
11.3.3.3. 4D Bioprinting Market for Other End-Users, 2023-2035
11.3.4. 4D Bioprinting Market, 2028 and 2035: Distribution by Key Geographical Regions
11.3.4.1. 4D Bioprinting Market in North America, 2023-2035
11.3.4.2. 4D Bioprinting Market in Europe, 2023-2035
11.3.4.3. 4D Bioprinting Market in Asia-Pacific, 2023-2035
11.3.4.4. 4D Bioprinting Market in Latin America, 2023-2035
11.3.4.5. 4D Bioprinting Market in Middle East and North Africa, 2023-2035
12. CONCLUDING REMARKS
13. EXECUTIVE INSIGHTS
13.1. Chapter Overview
13.2. Avay Biosciences
13.2.1. Company Overview
13.2.2. Interview Transcript: Suhridh Sundaram (Chief Operating Officer)
13.3. CURAM
13.3.1. Company Overview
13.3.2. Interview Transcript: Preethem Srinath (Doctoral Candidate)
13.3. Independent Consultant
13.3.1. Interview Transcript: Sam Onukuri
14. APPENDIX I: TABULATED DATA
15. APPENDIX II: LIST OF COMPANIES AND ORGANIZATIONS
Figure 2.1 Executive Summary: Current Market Landscape of 4D Bioprinters
Figure 2.2 Executive Summary: Current Market Landscape of Smart Biomaterials
Figure 2.3 Executive Summary: Publication Benchmarking Analysis
Figure 2.4 Executive Summary: Market Forecast and Opportunity Analysis
Figure 3.1 Steps Involved in Bioprinting
Figure 3.2 Steps Involved in 4D Bioprinting
Figure 3.3 Laws of 4D Printing Structures
Figure 3.4 Limitations Associated with 4D Bioprinting
Figure 4.1 4D Bioprinters: Distribution by Status of Development
Figure 4.2 4D Bioprinters: Distribution by Type of Biomaterial
Figure 4.3 4D Bioprinters: Distribution by Status of Development and Type of Biomaterial
Figure 4.4 4D Bioprinters: Distribution by Type of Technology
Figure 4.5 4D Bioprinters: Distribution by Status of Development and Type of Technology
Figure 4.6 4D Bioprinters: Distribution by Type of Stimulus Used
Figure 4.7 4D Bioprinters: Distribution by Status of Development and Type of Stimulus Used
Figure 4.8 4D Bioprinters: Distribution by Product Specifications
Figure 4.9 4D Bioprinters: Distribution by Application Area(s)
Figure 4.10 4D Bioprinters: Distribution by End-User(s)
Figure 4.11 4D Bioprinter Developers: Distribution by Year of Establishment
Figure 4.12 4D Bioprinter Developers: Distribution by Organization Size
Figure 4.13 4D Bioprinter Developers: Distribution by Location of Headquarters (Region-wise)
Figure 4.14 4D Bioprinter Developers: Distribution by Organization Size and Location of Headquarters (Region-wise)
Figure 4.15 4D Bioprinter Developers: Distribution by Location of Headquarters (Country-wise)
Figure 5.1 Smart Biomaterials: Distribution by Status of Development
Figure 5.2 Smart Biomaterials: Distribution by Type of Biomaterial
Figure 5.3 Smart Biomaterials: Distribution by Status of Development and Type of Biomaterial
Figure 5.4 Smart Biomaterials: Distribution by Form of Biomaterial
Figure 5.5 Smart Biomaterials: Distribution by Type of Stimulus Used
Figure 5.6 Smart Biomaterials: Distribution by Status of Development and Type of Stimulus Used
Figure 5.7 Smart Biomaterials: Distribution by Application Area(s)
Figure 5.8 Smart Biomaterials Developers: Distribution by Year of Establishment
Figure 5.9 Smart Biomaterials Developers: Distribution by Organization Size
Figure 5.10 Smart Biomaterials Developers: Distribution by Location of Headquarters (Region-wise)
Figure 5.11 Smart Biomaterials Developers: Distribution by Organization Size and Location of Headquarters (Region-wise)
Figure 5.12 Smart Biomaterials Developers: Distribution by Location of Headquarters (Country-wise)
Figure 6.1 Benchmarking Analysis (4D Bioprinter Developers): Distribution by Location of Headquarters and Organization Size
Figure 6.2 Competitive Benchmarking: Distribution of Very Small and Small Players based in North America (Peer Group I)
Figure 6.3 Competitive Benchmarking: Distribution of Mid-Sized, Large and Very Large Players based in North America (Peer Group II)
Figure 6.4 Competitive Benchmarking: Distribution of Very Small and Small Players based in Europe, Asia-Pacific and Rest of the World (Peer Group III)
Figure 6.5 Competitive Benchmarking: Distribution of Mid-sized Players based in Europe, Asia-Pacific and Rest of the World (Peer Group IV)
Figure 6.6 Competitive Benchmarking: Distribution of Large and Very Large Players based in Europe, Asia-Pacific and Rest of the World (Peer Group V)
Figure 6.7 Benchmarking Analysis (Smart Biomaterial Developers): Distribution by Location of Headquarters and Organization Size
Figure 6.8 Competitive Benchmarking: Distribution of Very Small and Small Players based in North America (Peer Group I)
Figure 6.9 Competitive Benchmarking: Distribution of Large and Very Large Players based in North America (Peer Group II)
Figure 6.10 Competitive Benchmarking: Distribution of Very Small and Small Players based in Europe, Asia-Pacific and Rest of the World (Peer Group III)
Figure 6.11 Competitive Benchmarking: Distribution of Mid-sized Players based in Europe, Asia-Pacific and Rest of the World (Peer Group IV)
Figure 6.12 Competitive Benchmarking: Distribution of Large and Very Large Players based in Europe, Asia-Pacific and Rest of the World (Peer Group V)
Figure 7.1 Product Competitiveness Analysis: Distribution of 4D Bioprinters Developed by North America based Players
Figure 7.2 Product Competitiveness Analysis: Distribution of 4D Bioprinters Developed by Europe based Players
Figure 7.3 Product Competitiveness Analysis: Distribution of 4D Bioprinters Developed by Asia-Pacific and Rest of the World based Players
Figure 8.1 Stratasys: Annual Revenues, 2017-H1 2022 (USD Million)
Figure 8.2 Enovis: Annual Revenues, 2017-H1 2022 (USD Billion)
Figure 9.1 Publication Benchmarking Analysis: Cumulative Year-wise Trend, 2016-2022
Figure 9.2 Publication Benchmarking Analysis: Distribution by Type of Article
Figure 9.3 Word Cloud Analysis: Emerging Focus Areas
Figure 9.4 Popular Publishers: Distribution by Number of Publications
Figure 9.5 Popular Journals: Distribution by Number of Publications
Figure 9.6 Publications Benchmarking Analysis: Distribution by Journal Impact Factor
Figure 9.7 Popular Journals: Distribution by Journal Impact Factor
Figure 9.8 Popular Funding Bodies: Distribution by Number of Publications
Figure 9.9 Publication Benchmarking
Figure 10.1 Porter’s Five Forces: Key Parameters
Figure 10.2 Porter’s Five Forces: Harvey Ball Analysis
Figure 11.1 Global 4D Bioprinting Market, 2023-2035 (USD Million)
Figure 11.2 4D Bioprinting Market: Distribution by Type of Technology, 2028 and 2035 (USD Million)
Figure 11.3 4D Bioprinting Market for Extrusion-based Technology, 2023-2035 (USD Million)
Figure 11.4 4D Bioprinting Market for Laser-based Technology, 2023-2035 (USD Million)
Figure 11.5 4D Bioprinting Market for Inkjet-based Technology, 2023-2035 (USD Million)
Figure 11.6 4D Bioprinting Market for Other Technologies, 2023-2035 (USD Million)
Figure 11.7 4D Bioprinting Market: Distribution by Application Area, 2028 and 2035 (USD Million)
Figure 11.8 4D Bioprinting Market for Biomedical Applications, 2023-2035 (USD Million)
Figure 11.9 4D Bioprinting Market for Other Applications, 2023-2035 (USD Million)
Figure 11.10 4D Bioprinting Market: Distribution by End-user, 2028 and 2035 (USD Million)
Figure 11.11 4D Bioprinting Market for Pharmaceutical and Biotechnology Companies, 2023-2035 (USD Million)
Figure 11.12 4D Bioprinting Market for Academic Research and Development, 2023-2035 (USD Million)
Figure 11.13 4D Bioprinting Market for Other End-users, 2023-2035 (USD Million)
Figure 11.14 4D Bioprinting Market: Distribution by Key Geographical Regions, 2028 and 2035 (USD Million)
Figure 11.15 4D Bioprinting Market in North America, 2023-2035 (USD Million)
Figure 11.16 4D Bioprinting Market in Europe, 2023-2035 (USD Million)
Figure 11.17 4D Bioprinting Market in Asia-Pacific, 2023-2035 (USD Million)
Figure 11.18 4D Bioprinting Market in Latin America, 2023-2035 (USD Million)
Figure 11.19 4D Bioprinting Market in Middle East and North Africa, 2023-2035 (USD Million)
Figure 12.1 Concluding Remarks: Current Market Landscape of 4D Bioprinters
Figure 12.2 Concluding Remarks: Current Market Landscape of Smart Biomaterials
Figure 12.3 Concluding Remarks: Publication Benchmarking Analysis
Figure 12.4 Concluding Remarks: Market Forecast and Opportunity Analysis
Table 4.1 4D Bioprinters: Information on Status of Development and Type of Biomaterial,
Table 4.2 4D Bioprinters: Information on Type of Technology and Type of Stimulus Used,
Table 4.3 4D Bioprinters: Information on Product Specifications, Application Area(s) and End-user(s)
Table 4.4 4D Bioprinters Developers: Information on Year of Establishment, Number of Employees, Company Size, Location of Headquarters
Table 5.1 Smart Biomaterials: Information on Status of Development, Type of Biomaterial and Form of Biomaterial,
Table 5.2 Smart Biomaterials: Information on Type of Stimulus Used and Application Area(s),
Table 5.3 Smart Biomaterial Developers: Information on Year of Establishment, Number of Employees, Company Size, and Location of Headquarters
Table 6.1 Benchmarking Analysis (4D Bioprinter Developers): Information on Peer Groups
Table 6.2 Benchmarking Analysis (Smart Biomaterial Developers): Information on Peer Groups
Table 8.1 4D Bioprinter Developers: List of Companies Profiled
Table 8.2 Poietis: Company Overview
Table 8.3 Poietis: Product Portfolio
Table 8.4 Poietis: Recent Developments and Future Outlook
Table 8.5 REGENHU: Company Overview
Table 8.6 REGENHU: Product Portfolio
Table 8.7 REGENHU: Recent Developments and Future Outlook
Table 8.8 ROKIT Healthcare: Company Overview
Table 8.9 ROKIT Healthcare: Product Portfolio
Table 8.10 ROKIT Healthcare: Recent Developments and Future Outlook
Table 8.11 SMART3D: Company Overview
Table 8.12 SMART3D: Product Portfolio
Table 8.13 SMART3D: Recent Developments and Future Outlook
Table 8.14 Stratasys: Company Overview
Table 8.15 Stratasys: Product Portfolio
Table 8.16 Stratasys: Recent Developments and Future Outlook
Table 8.17 VIVAX BIO: Company Overview
Table 8.18 VIVAX BIO: Product Portfolio
Table 8.19 VIVAX BIO: Recent Developments and Future Outlook
Table 8.20 Smart Biomaterial Developers: List of Companies Profiled
Table 8.21 DirectSync Surgical: Company Overview
Table 8.22 DirectSync Surgical: Product Portfolio
Table 8.23 DirectSync Surgical: Recent Developments and Future Outlook
Table 8.24 Enovis: Company Overview
Table 8.25 Enovis: Product Portfolio
Table 8.26 Enovis: Recent Developments and Future Outlook
Table 8.27 Ferentis: Company Overview
Table 8.28 Ferentis: Product Portfolio
Table 8.29 Ferentis: Recent Developments and Future Outlook
Table 8.30 Sculpteo: Company Overview
Table 8.31 Sculpteo: Product Portfolio
Table 8.32 Sculpteo: Recent Developments and Future Outlook
Table 9.1 Timeline Analysis: Distribution by Type of Article and Average Time to Publish
Table 9.2 Timeline Analysis: Distribution by Type of Article and Maximum Time to Publish
Table 9.3 Timeline Analysis: Distribution by Type of Article and Minimum Time to Publish
Table 9.4 Timeline Analysis: Distribution by Journal Impact Factor and Average Time to Publish
Table 9.5 Timeline Analysis: Distribution by Journal Impact Factor and Maximum Time to Publish
Table 9.6 Timeline Analysis: Distribution by Journal Impact Factor and Minimum Time to Publish
Table 9.7 Publication Benchmarking: List of Top 35 Publications
Table 13.1 Avay Biosciences: Company Overview
Table 13.2 CURAM: Company Overview
Table 14.1 4D Bioprinters: Distribution by Status of Development
Table 14.2 4D Bioprinters: Distribution by Type of Biomaterial
Table 14.3 4D Bioprinters: Distribution by Status of Development and Type of Biomaterial
Table 14.4 4D Bioprinters: Distribution by Type of Technology
Table 14.5 4D Bioprinters: Distribution by Status of Development and Type of Technology
Table 14.6 4D Bioprinters: Distribution by Type of Stimulus Used
Table 14.7 4D Bioprinters: Distribution by Status of Development and Type of Stimulus Used
Table 14.8 4D Bioprinters: Distribution by Product Specifications
Table 14.9 4D Bioprinters: Distribution by Application Area(s)
Table 14.10 4D Bioprinters: Distribution by End-user(s)
Table 14.11 4D Bioprinter Developers: Distribution by Year of Establishment
Table 14.12 4D Bioprinter Developers: Distribution by Organization Size
Table 14.13 4D Bioprinter Developers: Distribution by Location of Headquarters (Region-wise)
Table 14.14 4D Bioprinter Developers: Distribution by Organization Size and Location of Headquarters (Region-wise)
Table 14.15 4D Bioprinter Developers: Distribution by Location of Headquarters (Country-wise)
Table 14.16 Smart Biomaterials: Distribution by Status of Development
Table 14.17 Smart Biomaterials: Distribution by Type of Biomaterial
Table 14.18 Smart Biomaterials: Distribution by Status of Development and Type of Biomaterial
Table 14.19 Smart Biomaterials: Distribution by Form of Biomaterial
Table 14.20 Smart Biomaterials: Distribution by Type of Stimulus Used
Table 14.21 Smart Biomaterials: Distribution by Status of development and Type of Stimulus Used
Table 14.22 Smart Biomaterials: Distribution by Application Area(s)
Table 14.23 Smart Biomaterials Developers: Distribution by Year of Establishment
Table 14.24 Smart Biomaterials Developers: Distribution by Organization Size
Table 14.25 Smart Biomaterials Developers: Distribution by Location of Headquarters (Region-wise)
Table 14.26 Smart Biomaterials Developers: Distribution by Organization Size and Location of Headquarters (Region-wise)
Table 14.27 Smart Biomaterials Developers: Distribution by Location of Headquarters (Country-wise)
Table 14.28 Benchmarking Analysis (4D Bioprinter Developers): Distribution by Location of Headquarters and Organization Size
Table 14.29 Benchmarking Analysis (Smart Biomaterial Developers): Distribution by Location of Headquarters and Organization Size
Table 14.30 Stratasys: Annual Revenues, 2017-H1 2022 (USD Million)
Table 14.31 Enovis: Annual Revenues, 2017-H1 2022 (USD Billion)
Table 14.32 Publication Benchmarking Analysis: Cumulative Year-wise Trend, 2016-2022
Table 14.33 Publication Benchmarking Analysis: Distribution by Type of Article
Table 14.34 Popular Publishers: Distribution by Number of Publications
Table 14.35 Popular Journals: Distribution by Number of Publications
Table 14.36 Publications Benchmarking Analysis: Distribution by Journal Impact Factor
Table 14.37 Popular Journals: Distribution by Journal Impact Factor
Table 14.38 Popular Funding Bodies: Distribution by Number of Publications
Table 14.39 Global 4D Bioprinting Market, Conservative, Base and Optimistic Scenario, 2023-2035 (USD Million)
Table 14.40 4D Bioprinting Market: Distribution by Type of Technology, 2028 and 2035 (USD Million)
Table 14.41 4D Bioprinting Market for Extrusion-based Technology, Conservative, Base and Optimistic Scenario, 2023-2035 (USD Million)
Table 14.42 4D Bioprinting Market for Laser-based Technology, Conservative, Base and Optimistic Scenario, 2023-2035 (USD Million)
Table 14.43 4D Bioprinting Market for Inkjet-based Technology, Conservative, Base and Optimistic Scenario, 2023-2035 (USD Million)
Table 14.44 4D Bioprinting Market for Other Technologies, Conservative, Base and Optimistic Scenario, 2023-2035 (USD Million)
Table 14.45 4D Bioprinting Market: Distribution by Application Area, 2028 and 2035 (USD Million)
Table 14.46 4D Bioprinting Market for Biomedical Applications, Conservative, Base and Optimistic Scenario, 2023-2035 (USD Million)
Table 14.47 4D Bioprinting Market for Other Applications, Conservative, Base and Optimistic Scenario, 2023-2035 (USD Million)
Table 14.48 4D Bioprinting Market: Distribution by End-user, 2028 and 2035 (USD Million)
Table 14.49 4D Bioprinting Market for Pharmaceutical and Biotechnology Companies, Conservative, Base and Optimistic Scenario, 2023-2035 (USD Million)
Table 14.50 4D Bioprinting Market for Academic Research and Development, Conservative, Base and Optimistic Scenario, 2023-2035 (USD Million)
Table 14.51 4D Bioprinting Market for Other End-users, Conservative, Base and Optimistic Scenario, 2023-2035 (USD Million)
Table 14.52 4D Bioprinting Market: Distribution by Key Geographical Regions, 2028 and 2035 (USD Million)
Table 14.53 4D Bioprinting Market in North America, Conservative, Base and Optimistic Scenario, 2023-2035 (USD Million)
Table 14.54 4D Bioprinting Market in Europe, Conservative, Base and Optimistic Scenario, 2023-2035 (USD Million)
Table 14.55 4D Bioprinting Market in Asia-Pacific, Conservative, Base and Optimistic Scenario, 2023-2035 (USD Million)
Table 14.56 4D Bioprinting Market in Latin America, Conservative, Base and Optimistic Scenario, 2023-2035 (USD Million)
Table 14.57 4D Bioprinting Market in Middle East and North Africa, Conservative, Base and Optimistic Scenario, 2023-2035 (USD Million)
The following companies and organizations have been mentioned in the report:
Source 1: https://www.sciencedirect.com/science/article/pii/S1742706119307172#sec0015
Source 2: https://www.azom.com/article.aspx?ArticleID=19378
PRICING DETAILS
Discounts available for multiple report purchases
sales@rootsanalysis.com
YOU MAY ALSO LIKE
SUBSCRIBE TO INDUSTRY UPDATES